Endocrinology - Obesity and lipids

Obesity is a serious health problem that is increasing in society. Overweight and obesity are important risk factors for heart disease. Many risk factors for heart disease have been suggested in overweight and obese people, including dyslipidemia and irritability. Adiponectin, a hormone released by adipose tissue, has both weight loss and weight loss properties. Numerous studies have explained the relationship between adiponectin and obesity in different populations. LDL cholesterol plays an important role in this "diabetic dyslipidemia" and is considered to be severely atherogenic, a greater cause than a clear indication of increased risk. A variation known as VLDL, low-density lipoprotein, appears to be particularly dangerous—but it appears that increasing HDL, high-density lipoprotein cholesterol, can control its harmful activity or no decrease associated with LDL counts.

  • Elevated Cholesterol
  • Elevated Triglycerides
  • Elevated Triglycerides
  • Obesity/Metabolic Syndrome

Related Conference of Endocrinology - Obesity and lipids

September 09-10, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
September 25-26, 2024

5th World Summit on Diabetes Expo

Rome, Italy
October 14-15, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Endocrinology - Obesity and lipids Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in